A 65-year-old man presents with a mildly painful mass in the right side of his neck. He reports that it has been growing during the past few weeks. A biopsy of the mass is obtained. What is your diagnosis?
FDA, CMS, and Department of Veterans Affairs experts will be included. Dr. Robin Zon, a past chair of ASCO’s Government Relations Committee, said it is “critical” that the FDA work with providers and patients.
“Tumor cell–intrinsic factors shape the tumor immune microenvironment and influence the outcome of immunotherapy,” the lead study author concluded.
A 27-year-old woman presents with a right neck enlargement of a lymph node. She states that lately she has been fatigued, with a feeling of malaise. What is your diagnosis?
In the emerging era of personalized treatment, it may be time to rethink which surrogate markers are used in AML clinical trials.
TURBT with fluorescent light source using oral 5-ALA is well tolerated in non–muscle-invasive bladder cancer.
Novel Targeted Agents for Lung Cancer: M7824, a Bifunctional Protein Targeting PD-L1 and TGB-β Receptor II
In a phase I trial, this first-in-class novel drug yielded a 71% response rate in very high expressers of PD-L1 treated at 1,200 mg every 2 weeks.
A noncontrolled phase I study in recurrent metastatic glioblastoma showed 3-year survival was five times higher in patients treated with intratumoral PVSRIPO.
Melanoma patients who were treated with glucocorticoids for ipilimumab-induced hypophysitis had improved survival outcomes if they received low doses.
MGH Program Supports Sexual Health of Women Receiving Pelvic RT for Gastrointestinal and Gynecologic Malignancies
In an interview with Cancer Network, Lorraine Drapek describes a multidisciplinary program at MGH to support vaginal and sexual health post RT for GI and gynecologic malignancies.